Dealing with COVID-19-associated coagulopathy
Nederlands Tijdschrift voor Geneeskunde
; 164(18), 2020.
Article
in Dutch
| GIM | ID: covidwho-1717151
ABSTRACT
COVID-19 is associated with a high prevalence of activation of the coagulation cascade. It has been suggested that this so-called COVID-19-associated coagulopathy is predictive of a poor outcome and of mortality. Consensus documents on how to manage patients with COVID-19-associated coagulopathy are based on the limited number of mainly retrospective studies that is currently available, and for this reason the recommendations are not always consistent with one another. In this article, we review the first studies into COVID-19-associated coagulopathy and give the most important do's and don'ts for diagnostics and the daily management of coagulopathy and the prevention of complications in patients with, or with strongly-suspected, COVID-19 in Dutch clinical practice.
human diseases; mortality; retrospective studies; viral diseases; blood coagulation disorders; reviews; man; Netherlands; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Benelux; Developed Countries; European Union Countries; Kingdom of the Netherlands; OECD Countries; Western Europe; Europe; Covid-19; Coronavirus disease; Severe acute respiratory syndrome coronavirus 2; death rate; viral infections
Search on Google
Collection:
Databases of international organizations
Database:
GIM
Language:
Dutch
Journal:
Nederlands Tijdschrift voor Geneeskunde
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS